Sanjivani Paranteral Limited reported a strong performance for the quarter ended 31st December 2023

Sanjivani Paranteral Ltd (BSE: 531569) is a pharmaceutical company headquartered in Mumbai and two manufacturing plants at Navi Mumbai and Dehradun, specializing in the manufacturing and distribution of high-quality parenteral and oral solid products. We cater major therapeutic / product areas encompassing CNS, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.

Commenting on the results, Mr. Ashwani Khemka Chairman & Managing Director, Sanjivani Paranteral Ltd. said, "We are committed to setting new standards of excellence in patient care through our products and services. Our mission is to improve outcomes and enhance quality of life for individuals who rely on parenteral nutrition for their nutritional needs. The new geographies have performed quite well & we have a lot scope in these geographies. The fund raising has been completed."

Financial Summary:

Q3 FY24:

- Revenue from operation grew 64% YoY to Rs. 149.6 mn.
- EBITDA margin stood at 13.1% (up 298bps YoY) led by better price realization and favorable product mix.
- Profit After Tax (PAT) grew 73% YoY to Rs. 16.5 mn. PAT margin stood at 11.0% (up 59bps YoY).

Segment-wise Performance:

Injectables: Revenue grew 148% YoY to Rs. 95.8mn.
Oral: Revenue de-grew 34% YoY to Rs. 33.6mn.
Nutraceuticals: Revenue grew significantly YoY to Rs. 19.4mn in Q3FY24 vs Rs. 1.5mn in Q3FY23.

Market-Wise Performance:

- Exports (incl. Exports incentives) constitutes 64.8% of total revenue while domestic constitutes the rest.

Core markets of CIS (incl Russia), Middle east & Africa and Latin America, accounted for 60.5% to Rs. 90.2mn.

9M FY24:

- Revenue from operation grew 52% YoY to Rs. 415.5mn.

- EBITDA margin stood at 14.6% (down 75bps YoY) led by lower price realization in some products.

- Profit After Tax (PAT) grew 40% YoY to Rs. 49.1mn. PAT margin stood at 11.8% (down 103bps YoY).

Shares of Sanjivani Paranteral Limited was last trading in BSE at Rs. 160.35 as compared to the previous close of Rs. 165.75. The total number of shares traded during the day was 14620 in over 117 trades.

The stock hit an intraday high of Rs. 173.90 and intraday low of 159.00. The net turnover during the day was Rs. 2440677.00.

Source : Equity Bulls

Keywords

INE860D01013 SanjivaniParanteral Pharmaceuticals Q3FY24 ResultUpdate